Sakar Healthcare Quarterly Results for Trading Insights

In Sept 2025, Sakar Healthcare (SAKAR) reported revenue ₹59 Cr and net profit ₹5 Cr — revenue +37.2% YoY. For annual financials, live price and key ratios, visit Sakar Healthcare share price today.

Latest Quarter Net Profit
₹5 Cr
QSept 2025
Quarterly Results

SAKAR Quarterly Results — Revenue, Profit & EPS Highlights

Sakar Healthcare latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. Compare with Sakar Healthcare valuation methods to assess whether the stock is under or overvalued.

  • Revenue of ₹59 Cr in Sept 2025 (+18.0% vs Mar 2025, +37.2% vs Sept 2024)
  • Net Profit of ₹5 Cr in Sept 2025 (-16.7% vs Mar 2025, +0.0% vs Sept 2024)
  • EBITDA of ₹13 Cr in Sept 2025 (-18.8% vs Mar 2025)
  • Operating Margin of 20.0% in Sept 2025 (-11.0pp vs Mar 2025)
  • Earnings Per Share of ₹2.03 in Sept 2025 (-23.7% vs Mar 2025)

Sakar Healthcare Quarterly Results — Revenue, EBITDA, Net Profit & EPS

SAKAR quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric Sept 2025 Mar 2025 Jun 2025 Dec 2025 Sept 2024 QoQ YoY
Revenue (₹ Cr) 59 50 53 71 43 18.0% 37.2%
Net Profit (₹ Cr) 5 6 5 10 5 - -
EBITDA (₹ Cr) 13 16 13 19 12 - -
EPS (₹) 2.03 2.66 2.11 4.59 2.17 - -
Operating Margin (%) 20.0% 31.0% 24.0% 26.0% 27.0% - -

SAKAR Share Price Trend — 1-Year Movement Across Quarterly Results

Sakar Healthcare 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. Analyse SAKAR ownership pattern to track promoter, FII and institutional holdings.

Profitability Ratios

Profit Margin 8.5%
EBITDA Margin 22.0%
Operating Margin 20.0%
ROE (Annual) 7.0%

Balance Sheet Highlights

Total Assets ₹415 Cr
Total Equity ₹286 Cr
Current Assets ₹89 Cr
Current Liabilities ₹67 Cr

Cash Flow Analysis

Operating Cash Flow ₹34 Cr
Investing Cash Flow ₹-31 Cr
Financing Cash Flow ₹-4 Cr
Net Cash Flow ₹0 Cr

Current Market Data

Current Price ₹618.60
Exchange NSE
Last Updated Apr 13, 2026

Revenue Trend (₹ Cr)

Dec 2025 71
Jun 2025 53
Mar 2025 50
Sept 2025 59

Net Profit Trend (₹ Cr)

Dec 2025 10
Jun 2025 5
Mar 2025 6
Sept 2025 5

Operating Margin Trend (%)

Dec 2025 26.0%
Jun 2025 24.0%
Mar 2025 31.0%
Sept 2025 20.0%

SAKAR vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap

Sakar Healthcare latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Sept 2025 		₹396,418.12 Cr 1652.2 14,875 3,125 +10.8% - 21.0% 127.1
Divis Laboratories
Sept 2025 		₹162,373.86 Cr 6070.0 2,860 689 +7.1% - 24.1% 233.7
Torrent Pharmaceuti…
Sept 2025 		₹140,630.85 Cr 4181.0 3,219 591 +11.3% - 18.4% 238.4
Lupin
Sept 2025 		₹106,664.75 Cr 2315.1 6,921 1,485 +23.2% - 21.5% 71.5
Dr Reddys Laborator…
Sept 2025 		₹102,844.71 Cr 1235.9 9,135 1,337 +1.1% - 14.6% 76.4
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores